Mumbai, April 07, 2026: Global pharma major Lupin Limited (Lupin) today announced that it has received the prestigious Great Place To Work® certification, widely regarded as the gold standard for workplace excellence. The recognition marks a significant milestone as Lupin becomes one among select pharma companies to earn this certification through a truly global study spanning all its subsidiaries and geographies.
This prestigious certification underscores the deep commitment and active participation of Lupin employees, whose voices were central to the evaluation. Lupin recorded a robust 85% participation rate.
Commenting on the recognition, Yashwant Mahadik, President – Global Human Resources, Lupin, said, “We are honored to receive this global certification from Great Place To Work®. It reflects the strength of our inclusive and values-driven workplace culture, where employees across geographies feel respected, valued, and empowered to perform at their best. We remain committed to further strengthening our culture and continuously enhancing the employee experience across all our locations.”
Lupin has a permanent workforce of over 24,000 professionals across functions and geographies. In FY25, the company invested INR 40 billion on employee benefits and 1,253,456 hours on employee training.
About Lupin Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women's health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 24,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries - Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions. To know more, visit www.lupin.com or follow us on LinkedIn https://www.linkedin.com/company/lupin
For further information or queries, please contact:
Rajalakshmi Azariah Vice President & Global Head – Corporate Communications, Lupin rajalakshmiazariah@lupin.com
